Zag Bio™, Inc., a biotechnology company working to set a new standard for treating autoimmune disease, today announced it has advanced its lead program for Type 1 diabetes (T1D), ZAG-101, into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results